Medical Marijuana Dispensary Strive Life Grand Forks Opens to North Dakota Patients May 22nd
GRAND FORKS, N.D., May 21, 2019 (GLOBE NEWSWIRE) -- Item 9 Labs Corp. (OTC: INLB) (Item 9 Labs or the Company), a leader in comfortable cannabis health solutions for the modern consumer, today announced that medical marijuana dispensary Strive Life Grand Forks, a partner following the Company’s Strive Life business model and brand, will officially open on Wednesday, May 22nd, at 1809 13th Avenue North, in Grand Forks, North Dakota.
The operation will offer a diverse inventory of patient-focused products and will be open Tuesday through Friday, 10 a.m. – 7 p.m., and Saturday from 9 a.m. – 6 p.m.
Strive Life Grand Forks implements medical marijuana dispensary best practices from across the United States and globally. The dispensary model offered by Item 9 Labs features thoughtfully designed environments for an elevated patient experience.
Strive Life will offer a diverse inventory of quality products and quality medical cannabis solutions. We received a warm welcome from the Grand Forks community at our soft opening and now we are ready to serve North Dakota patients
stated Sara Gullickson, CEO of Item 9 Labs.
The invite-only family and friends event on May 17th offered a preview of the high-end retail space before product was introduced. Local government officials and community advocates were also in attendance.
My passion is people. I believe the most satisfying moments in life come when I can help others and lend a hand when it’s needed most. As trusted providers we look forward to advancing the wellness of patients
commented Strive Life Grand Forks co-owner Jonathan O’Keefe.
In November 2018, Strive Life Grand Forks received a permit to move forward with the medical marijuana program to obtain a dispensary registration certificate. The operation has a supply agreement with Pure Dakota, LLC, one of two licensed manufacturers of usable medical cannabis in North Dakota.
In addition to the Strive Life brand, Item 9 Labs is operating as licensed dispensaries, cultivation, and manufacturing facilities in multiple U.S. markets.
For information visit StriveGrandForks.com.
Item 9 Labs Corp. (OTC: INLB) creates comfortable cannabis health solutions for the modern consumer. The Company is bringing best of industry practices to markets from coast to coast through cultivation and production, distinctive retail environments, licensing services, and diverse product suites catering to different medical cannabis demographics. Item 9 Labs Corp. is headquartered in Phoenix, Arizona, with medical cannabis operations in multiple U.S. markets.
Item 9 Labs Corp.’s asset portfolio includes Dispensary Permits, Dispensary Templates, and Strive Life. These assets provide services specific to different stakeholder groups. Dispensary Permits is the Company’s consulting firm specializing in strategic license application and compliance. Dispensary Templates, a subdivision of the firm, is a technology platform with an extensive digital library of licensing and business planning resources. Strive Life is a turnkey dispensary model for the retail sector, elevating the patient experience with consistent and superior service, high-end design, and precision-tested products. It is currently being implemented in Arizona and North Dakota.
In addition, Item 9 Labs Corp. is advancing the industry with its dynamic product suites. The Company has created complementary brands Item 9 Labs and Strive Wellness to channel consumer diversity. Propriety delivery platforms include the Apollo Vape and Pod system, as well as a pioneering intra-nasal device. The Company has received multiple accolades for its medical-grade flower and concentrates.
Item 9 Labs Corp. will be managing cultivation, processing, distribution, and dispensary operations in up to ten U.S. markets by the end of 2019. Current facilities include distribution and processing operations Strive Wellness of Ohio and Strive Wellness of Nevada, as well as dispensary Strive Life North Dakota.
For more information, visit Item 9 Labs Corp. at www.Item9labscorp.com.
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties, including, but not limited to, risks and effects of legal and administrative proceedings and governmental regulation, especially in a foreign country, future financial and operational results, competition, general economic conditions, proposed transactions that are not legally binding obligations of the company and the ability to manage and continue growth. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. Important factors that could cause actual results to differ materially from the forward-looking statements we make in this news release include the introduction of new technology, market conditions and those set forth in reports or documents we file from time to time with the SEC. We undertake no obligation to revise or update such statements to reflect current events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.